Photodynamic therapy with verteporfin in mallatia leventinese
- 28 February 2002
- journal article
- Published by Elsevier BV in Ophthalmology
- Vol. 109 (2), 296-301
- https://doi.org/10.1016/s0161-6420(01)00927-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Macular dystrophy of malattia leventinese. A 25 year follow upBritish Journal of Ophthalmology, 1999
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophyNature Genetics, 1999
- Choroidal neovascularization in younger patientsCurrent Opinion in Opthalmology, 1999
- Indocyanine Green Angiography and Retinal Sensitivity After Photodynamic Therapy of Subfoveal Choroidal NeovascularizationSeminars in Ophthalmology, 1999
- Expanded Hypothesis on the Mechanism of Photodynamic Therapy Action on Choroidal NeovascularizationRetina, 1999
- Fundus-Autofluoreszenz bei Patienten mit vererbten Makuladystrophien, Malattia leventinese, familiär dominanten und altersbedingten DrusenKlinische Monatsblätter für Augenheilkunde, 1998
- Ultrastructural Findings in Autosomal Dominant DrusenAmerican Journal of Ophthalmology, 1997
- Macular Scatter ('Grid') Laser Treatment of Poorly Demarcated Subfoveal Choroidal Neovascularization in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1996
- Linkage of Autosomal Dominant Radial Drusen (Malattia Leventinese) to Chromosome 2p16-21American Journal of Ophthalmology, 1996